FDA Inspection Readiness
Former FDA investigators helping pharmaceutical, biotechnology, medical device, food, and cosmetics companies prepare for inspections, respond to FDA observations, and strengthen GMP compliance.
Step inside a regulated facility
Industry Universe
Explore cinematic walkthroughs of the facilities FDA investigators inspect. Each environment surfaces real risks, common 483 observations, and what investigators look for.
Pharmaceutical Manufacturing
From dispensing to packaging — every cGMP control under one roof.
Enter Environment
Biologics Manufacturing
Upstream, downstream, and aseptic fill — the biologics pressure points.
Enter Environment
Medical Device Manufacturing
Design controls, CAPA, and complaint handling under 21 CFR 820 / QMSR.
Enter Environment
Food Manufacturing
FSMA, allergen control, and environmental pathogen monitoring.
Enter Environment
Cosmetics Manufacturing
MoCRA compliance — adverse event reporting and facility registration.
Enter Environment
Compounding Pharmacy
USP <797>, <800>, and FDA 503B outsourcing facility expectations.
Enter Environment
QC Analytical Laboratory
HPLC, dissolution, stability, LIMS — and the data integrity that ties them together.
Enter Environment
Microbiology Laboratory
Sterility, endotoxin, EM — the sharp end of contamination control.
Enter Environment
Former FDA Investigators — Mock FDA Inspection Experts — FDA 483 Response Specialists
Why Choose Us
FDAInspections.com is led by former FDA investigators with direct agency experience helping regulated companies prepare for inspections, respond to observations, and improve inspection readiness.
Core Services
Comprehensive regulatory consulting from investigators who’ve been on both sides of the FDA inspection process.
Realistic mock inspections conducted by former FDA investigators to identify vulnerabilities before the agency arrives.
Learn MoreSystematic evaluation of your quality systems against current FDA expectations and cGMP requirements.
Learn MoreStrategic response development to address inspectional observations and prevent escalation to warning letters.
Learn MoreExpert remediation planning and corrective action implementation to resolve FDA enforcement actions.
Learn MoreCore Services
Access curated FDA enforcement data and trend analysis to stay ahead of regulatory developments.
Searchable intelligence on FDA warning letters across industries, with trend analysis and compliance insights to benchmark your regulatory posture.
Explore DataDetailed analysis of FDA 483 observations by category, helping companies anticipate inspection focus areas and prepare targeted responses.
Explore DataAre the Result of Your Quality System.
learn
Discover what needs to happen within the mandatory 15-business-day window following an FDA Form 483 issuance. This comprehensive timeline guide outlines day-by-day operational actions for pharmaceutical, medical device, and biologics…
Receiving an FDA Warning Letter represents an acute corporate event requiring immediate C-suite intervention. This executive roadmap outlines what senior leadership must execute during the first 72 hours and across…
Discover what an FDA mock inspection should include and determine the ideal operational timeline to schedule one. This comprehensive guide outlines the complete simulation lifecycle for life sciences manufacturers, CDMOs,…
Take Action
Don’t wait for a Form 483 or warning letter to take action. Our team of former FDA investigators will assess your readiness and build a tailored compliance strategy.
Common Questions
FDA inspection readiness means the facility, records, quality systems, and staff are prepared for FDA review before an investigator arrives.
An FDA Form 483 lists inspection observations. Companies should review each item, identify root causes, prepare corrective actions, and send a written response within the FDA response window.
Companies can prepare through mock inspections, GMP gap reviews, document checks, staff interview practice, CAPA review, and inspection-room planning.
FDA may issue a warning letter when inspection findings, product issues, records, responses, or repeated violations show that a company has not corrected regulatory problems.
A mock FDA inspection can find weak records, unclear staff answers, and quality system gaps before FDA sees them, giving the team time to correct problems.
FDA inspection help
$495
Buy the review, then send the intake details from the confirmation page.
Buy $495 ReviewUrgent support
Send the emergency request or call the listed phone number.
Get FDA HelpReceived a Form FDA 483?
Send the facts, deadline, and FDA document type. A former FDA investigator can review your situation and help you decide what to do next.
Sign in to access member resources, inspection tools and training.
New here? Create an account
